Mono Propylene Glycol (E1520) CAS: 57-55-6
Related Insights
Navigating Drug Shortages: Using IMO Incident Data to Mitigate Strait of Hormuz Supply Risks
The IMO dataset of 49 confirmed maritime incidents gives hospital pharmacy teams a structured roadmap to assess pharmaceutical exposure in the Gulf. By mapping API and chemical routes against high‑risk zones, procurement leaders can strategically plan Q3 logistics and safeguard patient care.
Caustic Soda and Chlor-Alkali: Gulf Competition Re-Enters as India Duty Resets
July 2026 is reshaping the chlor-alkali market as Gulf producers begin restoring caustic soda exports while India reinstates import duties after ending its emergency waiver. Procurement teams across Southeast Asia should immediately reassess sourcing strategy as regional supplier competitiveness enters a new phase.
Methanol Supply Risk in Q3 2026: What Hormuz Shipping Data Means for Buyers
Methanol buyers are facing a critical Q3 planning challenge as Strait of Hormuz transit remains far below normal levels. Physical shipping data now matters more than diplomatic signals when assessing supply availability and pricing risk.
GLP-1 Patent Era Begins in Earnest: What July 2026 Means for the Indian CDMO Race
The global GLP-1 market is entering a new phase as generic drug opportunities accelerate. Indian CDMOs are expanding peptide manufacturing capacity, making July 2026 a critical period for securing key raw materials such as TFA, pharmaceutical-grade DMF, and Fmoc amino acids.
Glycerin Pharmaceutical Grade: H1 Closing Review of EUDR and Supply Chain Challenges
Pharmaceutical-grade glycerin enters H2 2026 at the intersection of supply chain recovery and evolving sustainability regulations. Pharmaceutical buyers must balance USP/EP quality requirements with EUDR compliance while diversifying sourcing strategies.
War Risk Insurance for Hormuz Transits: Why Premiums Remain High Despite Supply Recovery in H1 2026
War risk insurance has become one of the biggest cost drivers for Gulf chemical shipments in H1 2026. This review explains why premiums remain elevated even as physical exports recover and what procurement teams should expect during H2 2026.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.